TY - JOUR
T1 - Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis
AU - Chalom, Elizabeth Candell
AU - Goldsmith, Donald P.
AU - Koehler, Melanie A.
AU - Bittar, Bassam
AU - Rose, Carlos D.
AU - Ostrov, Barbara E.
AU - Keenan, Gregory F.
PY - 1997/10
Y1 - 1997/10
N2 - Objective. To determine the prevalence and outcome of chronic uveitis in patients with juvenile rheumatoid arthritis (JRA). Methods. A retrospective analysis of 760 patients with JRA followed in 4 pediatric rheumatology centers. Patients with chronic uveitis were identified and their medical and ophthalmologic records were reviewed. Results. Seventy-four patients with uveitis were identified. The prevalence of uveitis was 9.3%. The mean interval from the onset of JRA to the onset of uveitis was 21 months, and 90% of the patients who developed uveitis did so within the first 4 years of their disease. Visual complications (synechiae, band keratopathy, cataract, or glaucoma) developed in 31% of the patients with uveitis. Complications were more common in patients who presented with uveitis early in the course of their JRA. Complications were also more common in antinuclear antibody (ANA) negative than in ANA positive patients. Visual loss to 20/50 or worse occurred in only 11% of patients with uveitis, and no patient became blind. Conclusion. In a very large cohort of patients with JRA, uveitis was uncommon and poor visual outcome was rare. Visual complications did not necessarily result in a poor outcome.
AB - Objective. To determine the prevalence and outcome of chronic uveitis in patients with juvenile rheumatoid arthritis (JRA). Methods. A retrospective analysis of 760 patients with JRA followed in 4 pediatric rheumatology centers. Patients with chronic uveitis were identified and their medical and ophthalmologic records were reviewed. Results. Seventy-four patients with uveitis were identified. The prevalence of uveitis was 9.3%. The mean interval from the onset of JRA to the onset of uveitis was 21 months, and 90% of the patients who developed uveitis did so within the first 4 years of their disease. Visual complications (synechiae, band keratopathy, cataract, or glaucoma) developed in 31% of the patients with uveitis. Complications were more common in patients who presented with uveitis early in the course of their JRA. Complications were also more common in antinuclear antibody (ANA) negative than in ANA positive patients. Visual loss to 20/50 or worse occurred in only 11% of patients with uveitis, and no patient became blind. Conclusion. In a very large cohort of patients with JRA, uveitis was uncommon and poor visual outcome was rare. Visual complications did not necessarily result in a poor outcome.
UR - http://www.scopus.com/inward/record.url?scp=0030810866&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030810866&partnerID=8YFLogxK
M3 - Article
C2 - 9330949
AN - SCOPUS:0030810866
VL - 24
SP - 2031
EP - 2034
JO - Journal of Rheumatology
JF - Journal of Rheumatology
SN - 0315-162X
IS - 10
ER -